<?xml version="1.0" encoding="UTF-8"?>
<p>Eight-week-old male wild-type (WT) C57BL/6J mice were purchased from Janvier (Le Genest-St-Isle, France). C57BL/6 
 <italic>Ifng</italic>
 <sup>
  <italic>-/-</italic>
 </sup> mice (&gt;10 backcrosses) were from the Jackson laboratory and 
 <italic>Ifnar</italic>
 <sup>
  <italic>-/-</italic>
 </sup> mice have been described previously [
 <xref rid="ppat.1007360.ref080" ref-type="bibr">80</xref>]. For infection with IAV and 
 <italic>S</italic>. 
 <italic>pneumoniae</italic>, mice were maintained in a biosafety level 2 facility in the Animal Resource Center at the Pasteur Institute, Lille. Mice were anesthetized and administered intranasally (i.n.) with 50Î¼l of PBS containing, or not (mock), 30 plaque forming units (PFUs) of the high-pathogenicity murine-adapted H3N2 IAV strain Scotland/20/74 or 100 PFUs of H1N1 IAV strain WSN/33. For superinfection, mice infected with H1N1 (A/WSN/33) were secondarily infected (4 dpi) with 10
 <sup>3</sup> CFUs of 
 <italic>S</italic>. 
 <italic>pneumoniae</italic> serotype 3 (ATCC 6303).
</p>
